Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Detalles Bibliográficos
Autores principales: Yeakel, John, Kannan, Aarthi, Rattigan, Nicole Hook, Yamamoto, Maki, Aleshin, Alexey, Harris, Jeremy P., Gao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626794/
https://www.ncbi.nlm.nih.gov/pubmed/34869814
http://dx.doi.org/10.1016/j.jdcr.2021.10.025
_version_ 1784606726675234816
author Yeakel, John
Kannan, Aarthi
Rattigan, Nicole Hook
Yamamoto, Maki
Aleshin, Alexey
Harris, Jeremy P.
Gao, Ling
author_facet Yeakel, John
Kannan, Aarthi
Rattigan, Nicole Hook
Yamamoto, Maki
Aleshin, Alexey
Harris, Jeremy P.
Gao, Ling
author_sort Yeakel, John
collection PubMed
description
format Online
Article
Text
id pubmed-8626794
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86267942021-12-02 Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient Yeakel, John Kannan, Aarthi Rattigan, Nicole Hook Yamamoto, Maki Aleshin, Alexey Harris, Jeremy P. Gao, Ling JAAD Case Rep Case Report Elsevier 2021-10-30 /pmc/articles/PMC8626794/ /pubmed/34869814 http://dx.doi.org/10.1016/j.jdcr.2021.10.025 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yeakel, John
Kannan, Aarthi
Rattigan, Nicole Hook
Yamamoto, Maki
Aleshin, Alexey
Harris, Jeremy P.
Gao, Ling
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_full Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_fullStr Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_full_unstemmed Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_short Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_sort bespoke circulating tumor dna as a biomarker for treatment response in a refractory merkel cell carcinoma patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626794/
https://www.ncbi.nlm.nih.gov/pubmed/34869814
http://dx.doi.org/10.1016/j.jdcr.2021.10.025
work_keys_str_mv AT yeakeljohn bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT kannanaarthi bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT rattigannicolehook bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT yamamotomaki bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT aleshinalexey bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT harrisjeremyp bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT gaoling bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient

Ejemplares similares